Antiverse Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $9.3M

  • Investors
  • 34

Antiverse General Information

Description

Developer of a drug discovery platform designed to predict antibody-antigen binding and provide antibody drug candidates against difficult targets. The company's platform uses machine learning and cell-free protein synthesis to predict antibodies that bind to a given antigen target with high affinity, enabling pharma companies and contract research organizations to speed up antibody hit discovery.

Contact Information

Website
www.antiverse.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sbarc, Spark 5th Floor
  • Maindy Road
  • Cardiff CF24 4HQ
  • Wales, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Big Data, LOHAS & Wellness, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Sbarc, Spark 5th Floor
  • Maindy Road
  • Cardiff CF24 4HQ
  • Wales, United Kingdom

Antiverse Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antiverse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series A) 20-Jan-2026 $9.3M Completed Generating Revenue
14. Seed Round 15-Oct-2024 Completed Generating Revenue
13. Seed Round 15-Mar-2021 Completed Generating Revenue
12. Seed Round 01-Nov-2020 Completed Generating Revenue
11. Grant 01-Jul-2020 Completed Generating Revenue
10. Accelerator/Incubator 01-Mar-2020 Completed Generating Revenue
9. Seed Round 01-Jan-2020 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
7. Accelerator/Incubator 23-Dec-2018 $25.4K $502K Completed Generating Revenue
6. Seed Round 08-Aug-2018 $262K $477K Completed Generating Revenue
To view Antiverse’s complete valuation and funding history, request access »

Antiverse Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 829,596 $0.000001 $0.31 $0.31 1x $0.31 11.28%
A Ordinary 370,000 $0.000001 $0.25 $0.25 1x $0.25 5.03%
To view Antiverse’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Antiverse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to predict antibody-antigen binding and provide antibody drug candidates
Discovery Tools (Healthcare)
Cardiff, United Kingdom
28 As of 2026

Tours, France
 

Rehovot, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Antiverse Competitors (6)

One of Antiverse’s 6 competitors is MAbSilico, a Accelerator/Incubator Backed company based in Tours, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MAbSilico Accelerator/Incubator Backed Tours, France
Biolojic Design Venture Capital-Backed Rehovot, Israel
Absci Formerly VC-backed Vancouver, WA
Exscientia Formerly VC-backed Oxford, United Kingdom
Molcure Venture Capital-Backed Kawasaki, Japan
To view Antiverse’s complete competitors history, request access »

Antiverse Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Antiverse Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202403777-D0 Binding molecules Inactive 15-Mar-2024
GB-202314107-D0 Binding molecules Inactive 15-Sep-2023
WO-2025056909-A1 Binding molecules Inactive 15-Sep-2023 C07K16/28

Antiverse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Antiverse Investors (34)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cardiff Capital Region Infrastructure Minority
DBW Investments Venture Capital Minority
Innovation Investment Capital PE-Backed Company Minority
Soulmates Ventures Accelerator/Incubator Minority
Totipotent Capital Venture Capital Minority
You’re viewing 5 of 34 investors. Get the full list »

Ready to get started?

Request a free trial

Antiverse FAQs

  • When was Antiverse founded?

    Antiverse was founded in 2017.

  • Where is Antiverse headquartered?

    Antiverse is headquartered in Cardiff, United Kingdom.

  • What is the size of Antiverse?

    Antiverse has 28 total employees.

  • What industry is Antiverse in?

    Antiverse’s primary industry is Discovery Tools (Healthcare).

  • Is Antiverse a private or public company?

    Antiverse is a Private company.

  • What is Antiverse’s current revenue?

    The current revenue for Antiverse is .

  • How much funding has Antiverse raised over time?

    Antiverse has raised $17.6M.

  • Who are Antiverse’s investors?

    Cardiff Capital Region, DBW Investments, Innovation Investment Capital, Soulmates Ventures, and Totipotent Capital are 5 of 34 investors who have invested in Antiverse.

  • Who are Antiverse’s competitors?

    MAbSilico, Biolojic Design, Absci, Exscientia, and Molcure are some of the 6 competitors of Antiverse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process